INTRODUCTION
============

Transcription factor families---groups of DNA-binding proteins that recognize the same *cis*-regulatory DNA element to modulate transcription---are found in all eukaryotes. Because individual members can perform different functions and can be expressed at different times, transcription factor families allow a broad range of expression responses for their transcriptional targets. To examine how target gene expression is coordinated among members of a transcription factor family, we examined a simple two-member family (Met31 and Met32) that is essential for regulating sulfur metabolism in the budding yeast, *Saccharomyces cerevisiae*.

Sulfur metabolism is involved in multiple facets of cellular metabolism and is regulated by a variety of environmental and intracellular cues ([@B30]; [@B1]; [@B5]; [@B61]; [@B10]; [@B21]). Met4 is the sole transcriptional activator of sulfur metabolism in budding yeast. Because it does not make energetic sense for all sulfur metabolism genes to be activated in response to every inducing signal, yeast must have mechanisms to select specific genes for expression as they are required. The Met4 activator is devoid of intrinsic DNA-binding ability and relies on interactions with DNA-binding cofactor proteins to target specific genes for transcription. These Met4 cofactors act solely as adaptors for recruiting Met4 to promoters and lack intrinsic transcriptional activation ability ([@B29]; [@B7]). There are two categories of DNA-binding Met4 cofactors: 1) Met31 and Met32 are highly similar C2H2 zinc finger proteins, and each binds a Met31/Met32 *cis*-regulatory element (with the consensus sequence of AAACTGTGGC), and 2) Cbf1 is a basic helix-loop-helix protein that homodimerizes to bind a Cbf1 *cis*-regulatory element (consisting of a CACGTGA motif; [@B54], [@B55]; [@B31]; [@B29]; [@B7]; [@B8]; [@B32]). Met4 recruitment to the DNA is further facilitated by Met28, which has been shown to bind and stabilize the DNA-bound Met4 complexes in vitro ([@B28]; [@B8]). A recent study suggested that Met28 binds a RYAAT motif that is found adjacent to Cbf1 sites in sulfur metabolism promoters ([@B51]).

We previously identified 45 bona fide targets of Met4 (referred to as the "Met4 core regulon") whose transcription is Met4 dependent under two different Met4-activating conditions: 1) sulfur limitation and 2) induced *MET4* expression in the absence of its negative regulator, Met30 ([@B32]). All Met4 core regulon promoters contain Met31/Met32 motifs, indicating an essential role for Met31/Met32 promoter binding in Met4-activated transcription. Only a subset of target promoters contains Cbf1 sites. Consistent with these findings, deletion of both Met31 and Met32 eliminates Met4-activated transcription of the entire Met4 core regulon, whereas loss of either Met28 or Cbf1 interferes with the induction of only a subset of Met4 targets. Promoter features, such as the presence of a Cbf1 site and a site containing a weak match to the Met31/Met32 consensus sequence, are predictors of Cbf1 and Met28 dependence ([@B32]). In addition, a RYAAT motif adjacent to the Cbf1 site was found to contribute to Cbf1- and Met28-responsive gene induction under low-sulfur conditions ([@B51]).

The DNA-binding domains of Met31 and Met32, which share 84% identity, show no differences in sequence specificity in vitro ([@B7]; [@B2]). Whereas Met31 and Met32 are redundant for growth in the absence of methionine ([@B7]), several studies indicate that Met31 and Met32 perform some distinct roles in the cell. First, *met32*Δ cells are significantly larger than *met31*Δ cells ([@B25]). Second, Met4-dependent growth responses are different in *met31*Δ and *met32*Δ cells. This difference is most apparent when Met4 and Met32 are not regulated by Met30, a component of the SCF^Met30^ ubiquitin ligase complex. SCF^Met30^ regulates Met4 by ubiquitylation using two mechanisms: 1) polyubiquitylation of Met4 targets Met4 to the proteasome for degradation, and 2) oligoubiquitylation of Met4 inhibits the transcriptional activation ability of the stable Met4 protein ([@B43]; [@B27]; [@B48]; [@B30]; [@B16]). Loss of Met30 results in a transcriptionally active form of Met4 that is not targeted for degradation. If Met4 activity is prolonged, a number of growth and cell cycle defects occur that lead to growth arrest and eventual cell death ([@B42]; [@B52]). Met4 and Met32 are the only confirmed ubiquitylation targets of SCF^Met30^ ([@B43]; [@B41]). Deletion of *MET4* or inactivating mutations within its transcription activation domain bypasses *met30*Δ lethality ([@B42]). Of the Met4 cofactors, only *MET32* deletion bypasses *met30*Δ lethality ([@B42]). Inactivating mutations within the DNA-binding domain of MET32 is also sufficient to bypass *met30*Δ lethality ([@B53]).

The prominent role of Met32 is further demonstrated when cells are exposed to cadmium. On exposure, Met30 is unable to target Met4 for ubiquitylation, and Met4 becomes active ([@B5]). As a result, sulfur metabolism genes are expressed, and the sulfur-containing antioxidant glutathione is produced in large quantities to allow cadmium detoxification ([@B35]; [@B15]). To shunt sulfur usage toward the production of glutathione, cells undergo a Met4-dependent shift from the use of commonly used sulfur-rich enzymes to isozymes lower in sulfur content ([@B15]). Consistent with the role Met4 plays in cadmium detoxification, *met4*Δ and *met31Δmet32*Δ cells are sensitive to cadmium ([@B5]). Although they are not as sensitive to cadmium as *met31Δmet32*Δ cells, *met32*Δ cells are more cadmium sensitive than *met31*Δ cells ([@B5]), supporting the notion that Met32 plays a greater role than Met31 in Met4-activated transcription when Met30 is inactive.

Because there are several documented distinctions between Met31 and Met32 upon Met30 inactivation, we characterized global transcriptional differences between cells lacking either Met31 or Met32 upon *MET4* expression when Met30 is inactive. On the basis of their transcriptional differences, we attempted to predict growth differences between the two deletion strains. We then characterized genome-wide DNA-binding patterns of Met4 and Met32 in vivo using chromatin immunoprecipitation and genomic tiling arrays. Finally, we examined Met31 and Met32 abundance upon expression of active Met4.

RESULTS
=======

Most growth differences between *met31*Δ and *met32*Δ cells were identified when Met30 function was abrogated, either permanently (in *met30*Δ cells) or transiently (upon exposure of cells to cadmium or temperature shift of the temperature-sensitive mutant *met30-6* strain; [@B42]; [@B5]; [@B52]). To identify transcriptional differences in the roles of Met31 and Met32 when Met30 is inactive, we expressed *MET4* in the absence of Met30 (*met30*Δ) in strains lacking either *MET31* or *MET32* (*met31*Δ or *met32*Δ) and analyzed the strains using genome-wide transcriptional microarrays. Genomic alterations allowed *MET4* to be expressed from the galactose-inducible *GAL1* promoter at its endogenous locus (*met4::GAL1-MET4*). Short-term expression of Met4 in the absence of Met30 resembles the physiological response of cells exposed to cadmium without eliciting cadmium-induced transcriptional programs that are independent of Met4 ([@B15]; [@B32]; Supplemental Figure S1). In addition, this experimental design allows investigation of differences between *met31*Δ and *met32*Δ cells without the need to factor in a multitude of Met30-mediated effects on Met4 and its cofactors ([@B27]; [@B48]; [@B30]; [@B16], [@B17]; [@B10]; [@B38]; [@B41]).

Although *MET32* deletion bypasses *met30*Δ lethality ([@B42]), it was unknown whether *MET32* deletion would bypass lethality instigated by the combination of Met30 loss and high *MET4* expression. Deletion of *MET32* alone (and deletion of both *MET31* and *MET32*) bypassed lethality caused by this condition, but deletion of *MET31* alone was not sufficient for bypass ([Figure 1A](#F1){ref-type="fig"}). Consistent with the difference in bypassing lethality, we identified clear *met31*Δ and *met32*Δ transcriptional differences upon galactose induction of *met4::GAL1-MET4 met30*Δ cells. Scatterplot comparisons of transcriptional profiles from *met31*Δ cells and its wild-type counterpart after 90 min of galactose induction showed that Met31 loss has little effect on the Met4 transcriptional signature ([Figure 1B](#F1){ref-type="fig"}). In contrast, approximately one-third of the Met4 core regulon genes, denoted by red diamonds in the scatterplot, failed to induce in the *met32*Δ background ([Figure 1C](#F1){ref-type="fig"}).

![Expression of Met4 in the absence of Met30 reveals distinct growth and transcriptional differences between *met31*∆ and *met32*∆ cells. (A) Loss of *MET32* bypasses lethality caused by combined Met30 loss and high Met4 expression. Serial dilutions of different *met4::GALMET4 met30*Δ strains were spotted onto rich media XY plates containing either glucose or galactose. (B) Scatterplot comparison of microarray profiles of *met4::GALMET4 met30*Δ cells with *met4::GALMET4 met30Δ met31*Δ cells after 90 min of galactose treatment in rich media. (C) Scatterplot comparison of microarray profiles of *met4::GALMET4 met30*Δ cells with *met4::GALMET4 met30Δ met32*Δ cells after 90 min of galactose treatment in rich media. Expression data are represented on a log~2~ scale. The number of ORFs compared is indicated at the bottom right of each graph.](1928fig1){#F1}

Of the 274 statistically significant transcripts shared among all profiles (p \< 0.05 following Loess and Bayesian normalization), 93 genes had induction Z-scores of 2 or higher after 90 min of galactose induction of *met4::GAL1-MET4 met30*Δ cells. Sixty-three of these 93 transcripts failed to reach induction Z-scores of 2 in *met4::GAL1-MET4 met30Δ met32*Δ cells. Induction of 37 of these transcripts depended on Met32 but not on Met31 (with Z-scores of ≥2 in *met4::GAL1-MET4 met30Δ met31*Δ cells). Functional specification (Funspec) analysis ([@B47]) of transcripts that solely depend on Met32 were enriched for genes involved in sulfate assimilation, ion transport, and allantoin/allantoate transport (Supplemental Figure S2). Although 27 of the 93 transcripts failed to reach induction Z-scores of 2 in the absence of Met31, only one statistically significant target solely depended on Met31 (and not Met32). This finding is consistent with the strong similarity of the *met31*Δ transcriptional profile to that of its wild-type counterpart ([Figure 1B](#F1){ref-type="fig"}). Twenty-nine transcripts remained induced (with a Z-score of ≥2) in both the *met31*Δ and *met32*Δ backgrounds. If these 29 genes are Met4 targets, Met31 and Met32 would be redundant for mediating their activation. These targets were enriched for most of the sulfur metabolic pathways (cysteine biosynthesis, methionine metabolism, homocysteine biosynthesis, AdoMet-homocysteine cycle, sulfate assimilation; Supplemental Figure S2).

Multiple Em for Motif Elicitation (MEME) analysis ([@B3]) of the promoter regions of the different gene groups revealed slightly different DNA consensus sequences for the Met31/Met32 motif ([Figure 2](#F2){ref-type="fig"}). The Met31/Met32 motif determined from the Met32-only--dependent promoters closely resembled the core regulon consensus Met31/Met32 sequence (grayscale motif; [@B32]). The redundant (Met31/Met32 independent) motif showed less emphasis on the cytosines that flank the central TGTGG sequence ([Figure 2](#F2){ref-type="fig"}). Both Met32-only--dependent and redundant gene sets contained CACGTGA Cbf1 motifs ([Figure 2](#F2){ref-type="fig"}). We previously defined the core regulon of Met4 and categorized it into three classes based on Cbf1/Met28 dependence ([@B32]). Class 1 consists of genes whose transcription depends on Cbf1 and Met28. Class 2 genes require Cbf1 and Met28 under the conditions of sulfur limitation but not upon *MET4* expression in the absence of Met30. Class 3 genes are induced independent of either Cbf1 or Met28. Investigation of *met31*Δ and *met32*Δ microarray profiles with respect to the core regulon showed a correlation between Met32-dependent transcripts and Cbf1/Met28 dependence (Pearson chi-squared p value = 0.0018), with the most-Met32-dependent transcripts found in the Cbf1/Met28-dependent class gene groups ([Figure 3](#F3){ref-type="fig"}, classes 1 and 2) and the least-Met32-dependent transcripts found in the Cbf1/Met28-independent class ([Figure 3](#F3){ref-type="fig"}, class 3). This correlation may be due to decreased *MET28* levels in *met32*Δ cells. *MET28* appears dependent on Met32 but not on Met31 ([Figure 3](#F3){ref-type="fig"}, class 2). Hierarchical clustering on the *met31*Δ and *met32*Δ microarray profiles with respect to sulfur metabolism genes identified transcripts that failed to induce in the absence of Met32 ([Figure 4A](#F4){ref-type="fig"}, red). Consistent with their correlation with Cbf1/Met28 dependency, many Met32-dependent transcripts lie on the upper half of the sulfur metabolic pathway ([Figure 4B](#F4){ref-type="fig"}, red). Clustering also identified targets that exhibited weak or delayed induction in *met32*Δ cells compared with its wild-type and *met31*Δ counterparts ([Figure 4A](#F4){ref-type="fig"}, blue).

![Met31/Met32 and Cbf1 promoter motifs for Met32-only--dependent and Met31/Met32-redundant targets. MEME determined position-specific scoring matrices (PSSMs) of Met31/Met32- and Cbf1-binding motifs from the promoters of genes with different transcriptional dependences. Previously published PSSMs based on the Met4 core regulon are shown as grayscale ([@B32]).](1928fig2){#F2}

![Microarray analysis of the Met4 core regulon shows that most Cbf1- and Met28-dependent target genes (class 1 and class 2) are Met32 dependent. Microarray transcriptional profiles of Met4 core regulon genes from wild-type, *met31*∆, *met32*∆, and *met31*∆ *met32*∆ strains genetically modified for galactose-induced active Met4 expression (*met4::GALMET4 met30*Δ) harvested at 15, 30, 60, and 90 min after galactose induction are compared with cells harvested before galactose induction. Z-score induction and repression are marked by red and green boxes, respectively (see scale). Core regulon genes are clustered into three classes (far left) based on Cbf1/Met28 dependence (see the text). Cbf1 and Met31/Met32 motifs within the promoters of these genes, as determined by MAST analysis, are indicated by black boxes (far right; [@B4]). Note that partial *MET30* transcripts can be detected because the *met30*∆ strain was constructed by an internal disruption of the gene ([@B56]).](1928fig3){#F3}

![Distinct sectors of the sulfur metabolic pathway are affected by Met32 loss. (A) Hierarchical clustering of microarray profiles on sulfur metabolism genes. Genes lacking visible microarray induction upon active Met4 in *met32*∆ cells are written in red, and genes showing weak or delayed microarray induction upon active Met4 expression in *met32*∆ cells compared with wild-type and *met31*∆ cells are written in blue. Genes that exhibit similar microarray profiles for wild-type, *met31*∆, and *met32*∆ cells are written in black. (B) Schematic of the sulfur assimilation pathway (adapted from [@B57]). Genes lacking visible microarray induction upon active Met4 in *met32*∆ cells are written in red. Cbf1- and Met28-dependent class 1 and class 2 genes are underlined. (C) Northern analysis of selected sulfur metabolism transcripts affected by Met32 loss.](1928fig4){#F4}

To further examine differences in Met32-dependent transcription, we performed Northern analysis on eight Met4 targets---four involved in sulfate assimilation (*MET3*, *MET14*, *MET22*, *MET16*) and four involved in the management of organic sulfur compounds (*MET17*, *MMP1*, *MUP1*, *GSH1*; [Figure 4C](#F4){ref-type="fig"}). As predicted, the absolute transcript levels for all examined sulfur metabolism genes were low before galactose induction in all strains. Northern analysis detected increases in the sulfate assimilation transcripts in *met32*Δ cells upon active Met4 expression, but these increases were significantly weaker or delayed compared with its wild-type and *met31*Δ counterparts. For *MET22*, the increase was less than twofold. Increases in other targets may have failed microarray detection in *met32*Δ cells due to low transcript levels. Consistent with microarray analyses, *MET17*, *MMP1*, and *MUP1* exhibited weak or delayed transcript induction. *GSH1*, the critical gene for glutathione synthesis, was induced less than twofold in *met32*Δ cells by both Northern and microarray analysis, consistent with the cadmium sensitivity of *met32*Δ cells ([@B5]).

On the basis of the transcriptional differences between *met31*Δ and *met32*Δ cells upon the induction of active Met4, we tested whether *met31*Δ and *met32*Δ cells exhibited different abilities in using sulfur compounds. We conducted yeast spot assays on *met31*Δ, *met32*Δ, *met4*Δ, *met31Δ met32*Δ, *cbf1*Δ, and *met28*Δ cells (lacking *met4::GAL1-MET4 met30*Δ alterations) on minimal media plates containing different levels of sulfate, sulfite, homocysteine, cysteine, and glutathione as sole sulfur sources ([Figure 5](#F5){ref-type="fig"}). Because all strains use methionine as a sole sulfur source, minimal media plates containing 0.1 mM methionine were used as controls ([Figure 5](#F5){ref-type="fig"}, top). Both *met4*Δ and *met31Δ met32*Δ cells failed to use sulfate, sulfite, cysteine, and glutathione as sole sulfur sources and were greatly impaired for growth on homocysteine-supplemented media, consistent with Met4 being the sole transcriptional activator of the sulfur metabolic pathway and our previous finding that Met4-activated transcription is lost in the absence of both Met31 and Met32 ([@B57]; [@B32]). In addition, both *cbf1*Δ and *met28*Δ cells failed to use sulfate and sulfite as sole sulfur sources. These findings are consistent with the key role of Cbf1 and Met28 in sulfate assimilation and previously reported reduced enzyme activities for sulfate assimilation in *cbf1*Δ cells ([@B55]; [@B32]). We also noticed that *cbf1*Δ and *met28*Δ cells grew less well at lower concentrations of homocysteine and glutathione compared with the highest concentration of 0.5 mM. Met31 and Met32 are redundant for use of sulfate, sulfite, homocysteine, cysteine, and glutathione as sole sulfur sources despite the clear transcriptional differences between *met31*Δ and *met32*Δ cells upon *MET4* expression in the absence of Met30.

![Strains lacking Met4 and Met4 cofactors exhibit different abilities to use common sulfur sources. Wild-type, *met4*∆, *met31*∆*met32*∆, *met31*∆, *met32*∆, *cbf1*∆, and *met28*∆ strains were serially diluted 10-fold and spotted onto minimal B-media agarose plates containing the indicated concentrations of sulfur compounds as the sole sulfur source. Images were taken after 3 d at 30°C.](1928fig5){#F5}

In addition to common sulfur compounds, wild-type yeast can use alternative sulfur sources such as sulfonates ([@B59]). We previously identified three genomic clusters of Met4-activated genes that are enriched for the metabolism of alternative sulfur sources ([@B12]; [@B22]; [@B49]; [@B19]; [@B32]). Hierarchical clustering on these gene groups revealed that genes involved in the transport and metabolism of sulfonates, such as *YIL166C*, *JLP1*, and *YLL058W*, were most affected by Met32 loss ([Figure 6A](#F6){ref-type="fig"}; [@B12]; [@B22]). Therefore, we examined the ability of *met31*Δ and *met32*Δ cells to use taurine, isethionate, and cysteate as sole sulfur sources and compared their growth with that of *met4*Δ, *met31Δ met32*Δ, *cbf1*Δ, and *met28*Δ cells ([Figure 6B](#F6){ref-type="fig"}). Both *met4*Δ and *met31Δmet32*Δ cells failed to use these compounds as sole sulfur sources. In addition, *cbf1*Δ and *met28*Δ cells also failed to use sulfonates. Despite their transcriptional differences, both *met31*Δ and *met32*Δ cells used all different concentrations of taurine, isethionate, and cysteate as sole sulfur sources ([Figure 6B](#F6){ref-type="fig"}).

![Strains lacking Met4 and Met4 cofactors exhibit different abilities to use sulfonates. (A) Hierarchical clustering of microarray profiles on the *GALMET4* chromosomal cluster genes. Genes lacking visible microarray induction upon active Met4 expression in *met32*∆ cells are shown in red. Genes that exhibit similar microarray profiles for wild-type, *met31*∆, and *met32*∆ cells are shown in black. (B) The indicated stains were serially diluted 10-fold and spotted onto B-media agarose plates containing the indicated concentrations of sulfur compounds as the sole sulfur source. Images were taken after 3 d at 30°C.](1928fig6){#F6}

Given that *met32*Δ cells were greatly impaired for *MET28* induction ([Figure 3](#F3){ref-type="fig"}) and *met28*Δ cells failed to use sulfate, sulfite, and sulfonates ([Figures 5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}), the ability of *met32*Δ cells to use these compounds was unexpected. *MET28* may be expressed at such low levels in *met32*Δ cells upon active Met4 expression that it failed microarray detection, as was the case for many Met32-dependent transcripts ([Figure 4A](#F4){ref-type="fig"} compared with [Figure 4C](#F4){ref-type="fig"}). To investigate this possibility, we examined *MET28* transcript levels upon galactose-induced expression of Met4 in the absence of Met30 by Northern analysis. Similar to microarray analyses, *MET28* was detected in *met31*Δ cells but not in *met32*Δ cells ([Figure 7A](#F7){ref-type="fig"}). Although *MET28* was not detected in *met32*Δ cells within 90 min of Met4 expression, *MET28* could have been expressed independent of Met32 under the conditions of the spot assay, which was performed on minimal media in cells that contain Met30. To investigate this possibility, we examined *MET28* transcript levels in cells with Met30 upon the Met4-activating condition of sulfur limitation in minimal media. Although *MET28* induction was impaired in *met31Δ met32*Δ cells upon sulfur limitation compared with wild-type cells, *MET28* transcripts were detected ([Figure 7B](#F7){ref-type="fig"}). These detectable levels of *MET28* may reflect different forms of *MET28* regulation between galactose induction of *met4::GAL-MET4 met30Δ met32*Δ cells and sulfur limitation of *met31Δ met32*Δ cells. This difference could affect recruitment of Met4 and allow strains in the yeast spot assay to express key genes to allow the use of different sulfur sources.

![Comparison of transcript profiles for *MET4*, *MET28*, *MET31*, and *MET32* under two different Met4-activating conditions: (A) Northern analysis of *MET4*, *MET28*, and *MET32* in indicated strains upon galactose induction in rich media. (B) Northern analysis of *MET4*, *MET28*, *MET31*, and *MET32* in wild-type and indicated deletion strains upon sulfur limitation in minimal media.](1928fig7){#F7}

To compare Met31 and Met32 promoter binding, we used genome-altered strains that contained Myc epitopes fused to the carboxyl termini of Met31 and Met32. Met31 and Met32 exhibited slightly different binding patterns. Consistent with our Northern data on transcript dependence, Met32 bound to promoters of the sulfate assimilation genes *MET14* and *MET16* and the glutathione synthesis gene *GSH1*, whereas Met31 did not, supporting the more important role of Met32 in the induction of Cbf1-dependent targets ([Figure 8](#F8){ref-type="fig"}). We previously compared Met31- and Met32-binding patterns to these promoters upon sulfur limitation in minimal media. On sulfur limitation, Met31 and Met32 exhibit similar relative profiles of promoter binding, with Met31 exhibiting strong binding to *MET14*, *MET16*, and *GSH1* relative to the other promoters analyzed ([@B32]). Differences in Met31 promoter-binding patterns between these two tested conditions may explain the discrepancy between the lack of sulfate assimilation gene induction upon galactose induction of *met4::GAL-MET4 met30Δ met32*Δ cells and the ability of *met32*Δ cells to use sulfate and sulfite as sole sulfur sources. Although the relative promoter-binding patterns for Met31 and Met32 were similar upon sulfur limitation, Met32^Myc^ had ∼10-fold higher percentage capture values than Met31^Myc^ upon sulfur limitation ([@B32]). We see a similar difference in percentage capture values between Met31 and Met32 upon Met4 expression in the absence of Met30 ([Figure 8B](#F8){ref-type="fig"}, different scales for Met31 and Met32). As a control, Met4 and Rpb3^HA^ exhibited very similar percentage captures in the two strains, which differ only in the Myc epitope--tagged target (Supplemental Figure S3).

![Differential binding of Met31 to Cbf1-independent target promoters upon induction of Met4 in the absence of Met30. (A) ChIP binding properties for Met4, Met31, Met32, and Rpb3 on indicated promoters before galactose induction (-- galactose) and after 90 min of galactose induction (+ galactose) of *met4::GAL-MET4 met30Δ MET31^MYC^ RPB3^HA^* and *met4::GAL-MET4 met30Δ MET32^MYC^ RPB3^HA^* cells. Promoter binding is represented by the color scale relative to the highest percentage capture detected for each immunoprecipitated factor (Met4, Myc, and hemagglutinin), which is arbitrarily set at 100. (B) Anti-Myc epitope ChIP of *met4::GAL-MET4 met30Δ MET31^MYC^ RPB3^HA^* and *met4::GAL-MET4 met30Δ MET32^MYC^ RPB3^HA^* cells. Percentage capture is represented as the percentage of the total promoter available. Samples of cells growing in raffinose were harvested (RAF, second bar grouping) before the addition of galactose and at 90 min after galactose treatment (GAL, third bar grouping). Background percentage capture levels were determined using protein A beads with no antibody on the same strains (first bar grouping).](1928fig8){#F8}

![Comparison of protein profiles for Met4, Cbf1, Met31, and Met32 under two different Met4-activating conditions. (A) Western analysis of Met4, Cbf1, Met31, and Met32 in *met4::GAL-MET4 met30Δ MET31^MYC^ RPB3^HA^* and *met4::GAL-MET4 met30Δ MET32^MYC^ RPB3^HA^* cells upon galactose induction in rich media. (B) Western analysis of Met4, Cbf1, Met31, and Met32 in wild-type or epitope-tagged *MET31^MYC^ RPB3^HA^* strains upon sulfur limitation in minimal media.](1928fig9){#F9}

![Characterization of in vivo genome binding for Met4 and Met32 using ChIP-chip. (A) Venn diagram of genome-wide Met4 and Met32 DNA targets upon active Met4 expression. Each circle represents the number of targets bound by Met4 (red circle) or Met32 (blue circle) as determined by analysis outlined in *Materials and Methods*. (B) ChIP-chip experiments (middle) are shown for Met4 and Met32 after 90 min of galactose induction. Each row represents a promoter region of a specific gene occupied by at least one factor. Expression profiles at different induction time points are shown for each gene (left). ChIP-chip data are presented on a yellow--blue enrichment scale (black indicates no binding), and gene expression data are presented on a green--red log~2~ scale (gray indicates unreliable measurements). Genes with MAST-determined matches to the Met4 core regulon--determined Met31/Met32 and Cbf1 motifs are marked by black boxes (right) (E value cutoff, 500; [@B4]). (C) MEME-determined PSSMs of Met31/Met32- and Cbf1-binding motifs from the promoters that were most bound by Met4 and Met32 in ChIP-chip studies, respectively. Associated E values are listed.](1928fig10){#F10}

![Binding charts of Met4 and Met32 to the promoter regions of selected target genes. The genomic positions of probe regions and their enrichment ratios are displayed on the *x*- and *y*-axes, respectively. Below the graph, ORFs are depicted as rectangles, and arrows indicate the direction of transcription. The heat map data from the galactose induction time course on *met4::GALMET4 met30*Δ cells as published in [@B32]) is shown above for each target except for the *MET31* and *MET32* heat maps, which are based on the present microarray analysis of *met4::GALMET4 met30*Δ cells. Increases greater than twofold compared with the 0-min sample are marked by red boxes. Decreases greater than twofold are marked by green boxes. Less-than-twofold changes in transcription are represented by black boxes, and unreliable measurements are marked by gray boxes. (A) Sulfur metabolic genes, (B) sulfur-saving glycolytic genes, (C) *MET4* and *MET30* (note that endogenous *MET4* and *MET30* promoters remain intact), (D) Met4 cofactor genes, and (E) *ACT1*.](1928fig11){#F11}

Despite many parameters that differ between these two Met4-activating conditions (galactose induction of *met4::GAL-MET4 met30*Δ cells in rich media or sulfur limitation in minimal media), we detected consistent differences between Met31 and Met32 expression ([Figures 7](#F7){ref-type="fig"} and [9](#F9){ref-type="fig"}). Transcriptional microarrays on *met4::GAL-MET4 met30*Δ cells showed that *MET32* levels increase with active Met4 expression but showed no change in *MET31* ([Figure 4A](#F4){ref-type="fig"} and [Figure 11D](#F11){ref-type="fig"} later in the paper). Northern analysis confirmed this *MET32* pattern ([Figure 7A](#F7){ref-type="fig"}), although a high background-to-signal ratio prevented *MET31* assessment. The patterns of Met31 and Met32 steady-state protein levels mimicked microarray patterns of *MET31* and *MET32*, respectively ([Figure 9A](#F9){ref-type="fig"}). Met31 was maintained at a constant level, whereas Met32 accumulated with active Met4 expression. These data support differential regulation of *MET31* and *MET32*, with *MET32* as a Met4 target gene and *MET31* as a nontarget. Likewise, *MET32* and *MET31* maintained these profiles upon sulfur limitation ([Figure 7B](#F7){ref-type="fig"}). As before, *MET32* transcript and Met32 protein accumulated with the active form of Met4 (phosphorylated and deubiquitylated; [Figures 7B](#F7){ref-type="fig"} and [9B](#F9){ref-type="fig"}). This induction was lost in *met4*Δ cells ([Figure 7B](#F7){ref-type="fig"}), consistent with *MET32* as a Met4 target gene. *MET31* transcripts and Met31 protein remained unchanged upon sulfur limitation in both wild-type and *met4*Δ cells ([Figures 7](#F7){ref-type="fig"} and [9](#F9){ref-type="fig"}), consistent with *MET31* not being a target of Met4. Accumulation of Met32 may contribute to its greater impact on the Met4-activated transcription compared with Met31 ([Figure 1, B](#F1){ref-type="fig"} and [C](#F1){ref-type="fig"}). Cbf1 protein levels remained unchanged in both time courses ([Figure 9](#F9){ref-type="fig"}).

To get a mechanistic understanding of the prominent role of Met32 in Met4-activated transcription when Met30 is absent, we identified and characterized in vivo binding targets of Met4 and Met32 by conducting chromatin immunoprecipitation (ChIP) studies using genomic tiling arrays (ChIP-chip) after 90 min of galactose induction on *met4::GAL-MET4 met30*Δ cells. Anti-Met4 antibodies immunoprecipitated 250 genomic targets that exhibited a significant enrichment compared with control samples that lacked antibody ([Figure 10A](#F10){ref-type="fig"}). Microarray data indicated a distinct correlation between Met4 promoter occupancy and transcriptional induction ([Figure 10B](#F10){ref-type="fig"} and Supplemental Figure S4). As expected, Met4-bound targets are highly enriched for sulfur metabolism genes and included 39 of the 45 core regulon promoters ([Figure 10B](#F10){ref-type="fig"} and Supplemental Figure S5). The highest Met4 captured targets ([Figure 10B](#F10){ref-type="fig"}, yellow in Met4 ChIP lane) were enriched for both Cbf1 and Met31/Met32 sites as determined by MAST analysis ([Figure 10B](#F9){ref-type="fig"}, black bands in MAST lanes; Pearson chi-squared analyses, p \< 0.005; [@B4]. Consistent with its prominent role in Met4-activated transcription, ChIP-chip studies showed that Met32 bound all identified Met4-bound DNA targets ([Figure 10A](#F10){ref-type="fig"}). Although original ChIP-chip analyses (as outlined in *Materials and Methods*) identified three Met4-bound targets not bound by Met32 in a statistically significant manner, closer examination of tiling arrays showed these three targets bound by Met32 (Supplemental Figure S6). Targets of Met4 and Met32 were enriched for sulfur metabolism genes in addition to stress response and various transport genes (Supplemental Figure S7).

MEME analysis of the top 130 Met4- and Met32-bound promoters revealed that Met31/Met32 and Cbf1 motifs closely matched the core regulon consensus sequences ([Figure 10C](#F10){ref-type="fig"} compared with [Figure 2](#F2){ref-type="fig"}, gray motifs). Given the large overlap between Met4-bound and Met32-bound targets, sequence differences were minimal. When nonpromoter targets were included in the analysis, MEME occasionally identified a core TGTGGC Met31/Met32-binding sequence in addition to the full Met31/Met32 motif (Supplemental Figure S8). If analysis included 180 bound regions, MEME-CHIP identified Cbf1 motifs that contained a flanking AAT motif in both Met4- and Met32-bound targets that matched part of the RYAAT motif found in Cbf1- and Met28-responsive promoters (Supplemental Figure S8; [@B37]; [@B51]).

Close examination of tiling arrays showed almost identical binding patterns for Met4 and Met32 at individual targets, further supporting Met32 as the main anchor for Met4 promoter binding ([Figure 11](#F11){ref-type="fig"}). Most Met4 and Met32 binding occurred at or near promoters ([Figure 11](#F11){ref-type="fig"}). Sulfur metabolism genes with known Met31/Met32 promoter sites exhibited significant promoter binding by Met32 and Met4 ([Figure 11A](#F11){ref-type="fig"}). Strong Met4 and Met32 promoter binding was also detected at known Met4 targets *ENO1* and *PDC6*, which encode glycolytic enzymes of low sulfur content ([Figure 11B](#F11){ref-type="fig"}; [@B15]; [@B44]; [@B13]). In addition, Met4 and Met32 bound the endogenous *MET4* and *MET30* promoters, consistent with known feedforward and feedback regulation of Met4 ([Figure 11C](#F11){ref-type="fig"}). Of Met4 cofactors, Met4 and Met32 bound genomic regions associated with *MET28*, *MET31*, and *MET32* but not *CBF1* ([Figure 11D](#F11){ref-type="fig"}). Whereas Met4 and Met32 bound promoters of *MET28* and *MET32*, Met4 and Met32 bound the *MET31* open reading frame (ORF; [Figure 11D](#F11){ref-type="fig"}). Examination of the *MET31* ORF revealed a full Met31/Met32 consensus binding sequence at the region corresponding to the largest ratios of Met4 and Met32 binding; the *MET32* ORF, which is not bound by Met32 or Met4, lacks this full motif (Supplemental Figure S9). In addition to *MET31*, 47 other targets were bound by Met4 and/or Met32 at their ORF or 3′ intergenic regions. These targets failed to induce upon induction of active Met4, either suggestive of roles for Met4 and Met32 that are independent of transcriptional activation or an indication of inappropriate binding by Met4 and Met32 to nontargets due to their high protein levels (Supplemental Figure S1C and [Figure 9A](#F9){ref-type="fig"}). Although Met4 and Met32 binding to these targets may be an artifact, MEME analysis indicated Met31/Met32 motifs in all retrievable ORFs, showing a strong consensus to an abbreviated CTGTGGC motif (Supplemental Figure S10). These atypical targets were enriched for osmosensing and tRNA processing (Supplemental Figure S10).

In addition to Met4-bound targets, ChIP-chip analyses identified 54 targets that registered as Met32 bound but not Met4 bound ([Figure 10A](#F10){ref-type="fig"}). These "Met32-only"--bound targets did not contain matches to either Met31/Met32 or Cbf1 motifs as determined by MAST and were not induced upon active Met4 expression. In fact, several Met32-only--bound targets were ribosomal protein genes that were repressed upon Met4 expression (Supplemental Figure S6 and [Figure 10B](#F10){ref-type="fig"}). Met32-only targets were also enriched for carbon metabolic pathways (glycolysis, gluconeogenesis, pentose phosphate shunt) and steroid metabolism (Supplemental Figure S11). Closer examination of most Met32-only targets indicated less Met32 binding compared with known Met4 targets and low levels of Met4 at the precise locations bound by Met32 (Supplemental Figure S11). Because most of these Met32-only transcripts were not induced upon Met4 expression, Met32 may perform roles beyond Met4-activated transcription. Alternatively, this binding may be an artifact of high Met32 levels in this growth condition ([Figure 9A](#F9){ref-type="fig"}). If there is a role for Met32 beyond Met4-activated transcription, many Met32-only--bound regions contained multiple genes, confounding identification of relevant targets (Supplemental Figure S11). Whereas MEME analysis failed to identify Met31/Met32 or Cbf1 motifs among these targets, the binding motif for Rap1 was identified, consistent with enrichment for ribosomal protein genes (Supplemental Figure S11). Excess Met32 and Met4 may simply be drawn to these nontargets through interactions with the basal machinery, as Rap1/Gcr1 activation occurs at nuclear pore--associated transcription factories and potentially accounts for \>75% of mRNA production in logarithmically growing cells ([@B39]). In support of this hypothesis, Met4 and Met32 also bound to the highly expressed *GAL* promoters upon galactose induction despite the lack of Met31/Met32 sites in these promoters (Supplemental Figure S12). Like Rap1/Gcr1--activated genes, the *GAL* genes are transcribed at high levels upon galactose induction and are known to localize to the nuclear periphery, where transcription factories are found ([@B6]).

DISCUSSION
==========

We originally chose to study the condition of Met4 expression in the absence of Met30 to mimic the physiological Met4 activation response seen upon cadmium exposure without eliciting cadmium responses that were independent of Met4, which would obscure the Met4 transcriptional profile (Supplemental Figure S1). However, higher levels of active Met4 are produced when Met4 is expressed from the *GAL1* promoter in the absence of Met30 compared with levels seen upon cadmium exposure (Supplemental Figure S1C). The overabundance of Met4 and Met32 in the absence of Met30 appears to produce artifacts in genome binding. Under these conditions, Met4 and Met32 were drawn to nontarget genes undergoing robust transcription, such as ribosomal protein and galactose metabolism (*GAL*) genes (Supplemental Figures S11 and S12). Although expression of Met4 in the absence of Met30 may result in binding artifacts, Met4 is transcriptionally active in this condition (Supplemental Figure S1) and preferentially binds known target genes. Previous ChIP-chip analyses characterized Met4, Met31, and Met32 in rich media or in response to the branched amino acid inhibitor sulfometuron methyl (SM) in synthetic complete media ([@B33]; [@B20]). Unfortunately, SM addition causes severe repression of *MET* genes, and Met4 is inhibited by Met30 in rich media ([@B24]; [@B30]; [@B32]). Reflecting this lack of Met4 activity, Met4 and Met32 only bound ∼31% of Met4 core regulon targets in this previous ChIP-chip study (Supplemental Figure S5, left). In contrast, we found that Met4 and Met32 bound ∼89% of core regulon targets in our study (Supplemental Figure S5, right). Therefore, although artifacts in genome binding may exist, our ChIP-chip analysis offers the best in vivo genome-wide representation of Met4 and Met32 binding when Met4 is known to be transcriptionally active.

Analysis of Met4 expression in the absence of Met4 may also shed light on the physiological problems cells experience when undergoing *met30*Δ lethality. Upon loss of Met30, cells undergo G1 arrest, growth arrest, and lethality, with defects in translation ([@B42]). We previously showed that Met4 expression in the absence of Met30 causes decreased transcript levels for ribosomal protein (RP) genes and glycolysis genes ([@B32]). The decrease in *RP* transcripts upon active Met4 expression was bypassed when *MET31* and *MET32* were deleted ([@B32]). Glycolytic and RP genes exhibited Met32 binding without significant Met4 binding and were not induced in a Met4-dependent manner (Supplemental Figure S11). We also noticed strong Met32 and Met4 binding to the promoter of the glycolytic nontarget gene *PGK1* (Supplemental Figure S12). It is possible that excess Met32 binds these promoters and somehow interferes with activation of these genes in this condition.

Both full and core Met31/Met32 motifs were identified among Met4/Met32-bound targets, which included promoters, ORFs, and 3′ intergenic regions (Supplemental Figures S8 and S10). The core CTGTGGC consensus sequence was identified among Met4- and Met32-bound ORFs. It is unknown whether Met4 or Met32 performs any role at open reading frames, but given our microarray profiles, it appears to be independent of Met4-activated transcription. Gcn4, a transcriptional activator of amino acid biosynthesis genes, binds coding regions in addition to promoter targets ([@B58]). When ORF bound, Gcn4 recruits the chromatin-modifying SAGA complex but not the mediator complex ([@B58]). Like Gcn4, Met4 recruits both mediator and SAGA complexes when it is promoter bound ([@B34]). Given this similarity, Met4 may also recruit SAGA but not mediator when ORF bound. Previous studies determined that Met4 and Met32 bind the promoter of the sulfur-saving Met4 target *PDC6* via core Met31/Met32 sites that consist of the CTGTGGC sequence and that inclusion of *PDC6* as a Met4 target appears to be a relatively recent evolutionary event ([@B13]). MEME identified this abbreviated motif in both ORF- and promoter-bound targets of Met4 and Met32.

Abundance of Met31 and Met32 likely contributes to their functional roles in transcription. Our previous genome-wide transcriptional analyses of *met4::GAL-MET4 met30*Δ cells using microarrays with entire cDNAs showed no changes in either *MET31* and *MET32* transcript levels with galactose induction ([@B32]), whereas our present study involving microarrays with 70-mer oligos showed increases for *MET32* with no increase for *MET31*. Because Met31 and Met32 are highly similar, especially within their DNA-binding domains ([@B7]), it is likely that cross-hybridization in the microarrays that contained the full cDNAs of *MET31* and *MET32* obscured detection of different *MET31* and *MET32* patterns. In addition, our previous Western analyses against tagged Met31 and Met32 at 1 h after sulfur limitation showed no differences between Met31 and Met32 levels ([@B32]). Our present examination at 0, 20, 40, and 80 min after sulfur limitation allowed us to better assess differences in the relative levels of Met31 and Met32 ([Figure 9](#F9){ref-type="fig"}).

Previous protein-binding arrays characterized binding motifs and/or binding affinities for Met4, Met31, and Met32 ([@B2]; [@B51]). Protein-binding arrays using in vitro translated glutathione *S*-transferase (GST) fusion proteins with the DNA-binding domains of Met31 and Met32 found no differences in DNA-binding motifs for Met31 and Met32 (both bound TGTGGCG; [@B2]). This finding indicates that the DNA-binding domains of Met31 and Met32, which share 84% identity, show no intrinsic differences in sequence specificity. Given that Met4-activated transcription is mediated by a complex of proteins, protein--protein interactions with Met4 and other factors are likely to play a role in differentiating Met31 and Met32 in terms of Met4 recruitment and/or target selection. Our in vivo ChIP study revealed that Met32 overlapped precisely with all Met4-bound regions, supporting Met32 as the main platform for Met4. Consistent with Met32 serving as a main platform for Met4 binding, in vitro protein-binding arrays using purified full-length Met4 and Met32 GST fusion proteins showed that Met4 exhibited Met32-dependent binding to sequences that scaled with the binding affinity of Met32 ([@B51]). The addition of full-length GST-Met28 fusion proteins had no effect on Met4 binding, indicating that Met32 recruitment of Met4 is independent of Met28 in this system ([@B51]). If Met31 binding and/or recruitment of Met4 is altered by the presence of Met28, different transcriptional responses could be elicited from these similar transcription factors. Further characterization of protein--protein interactions with respect to DNA-binding affinity and specificity will be required to obtain a systems view of transcriptional regulation by the Met4 complex.

In characterizing the role of Met31 and Met32 in Met4-activated transcription, we identified Met4 targets that depend on Met32 for full induction when Met4 expression is induced in the absence of Met30. Many of these targets fell within the upper half of the sulfur metabolic pathway, were Cbf1 and Met28 dependent, and exhibited weak or delayed induction in *met32*Δ cells. Altered induction kinetics may be due to reduced or absent *MET28* ([Figure 7](#F7){ref-type="fig"}), which would result in less Met28 to facilitate formation of stable, DNA-bound Met4 transcriptional complexes that contain Cbf1 and/or Met31. Despite reduced transcripts for critical sulfate and sulfonate metabolism genes, *met32*Δ cells used sulfate, sulfite, taurine, isethionate, and cysteate as sole sulfur sources in minimal media ([Figures 5](#F5){ref-type="fig"} and [6](#F6){ref-type="fig"}). To resolve this discrepancy, we examined several aspects of the Met4 transcriptional complex in the two tested conditions (of sulfur limitation of wild-type cells in minimal media and galactose induction of *met4::GAL-MET4 met30*Δ cells in rich media) and identified a clear difference in Met31 promoter binding to the Cbf1-dependent targets of *MET14*, *MET16*, and *GSH1* ([Figure 8](#F8){ref-type="fig"}; [@B32]). Both Met31 and Met32 bound to these promoters upon sulfur limitation in minimal media ([@B32]). This finding potentially explains how *met31*Δ and *met32*Δ cells use sulfate and sulfite in the yeast spot assays ([Figure 5](#F5){ref-type="fig"}). In contrast, Met31 exhibited poor binding to the promoters of sulfate assimilation genes and *GSH1* upon galactose induction of *met4::GAL1-MET4 met30*Δ cells, whereas Met32 bound these targets ([Figure 8](#F8){ref-type="fig"}). This finding could explain the lack induction for sulfate assimilation genes in *met4::GAL1-MET4 met30Δ met32*Δ cells ([Figure 4](#F4){ref-type="fig"}) and the sensitivity of *met32*Δ cells to cadmium (which requires Gsh1-mediated production of glutathione for detoxification) compared with the resistant *met31*Δ cells ([@B5]). Unfortunately, the mechanism by which Met31 exhibits differential promoter binding is unclear, as several parameters, such as growth media, Met30 functionality, and promoter regulation of Met4, differ between the two conditions. Given that Met30 is critical for targeting Met32 for ubiquitin-mediated degradation ([@B41]), it is reasonable that Met32 plays a greater role in Met4-activated transcription when Met30 is nonfunctional. In addition to effects mediated by Met30, Met4 plays a key role in modulating Met32 function, as Met4 appears to protect Met32 from ubiquitin-mediated degradation by another unidentified ubiquitin ligase ([@B41]). A comprehensive understanding of the dynamics connecting Met4, its DNA-binding cofactors, Met30, and other regulators and how these dynamics affect Met4-activated transcription will require further study.

MATERIALS AND METHODS
=====================

Yeast strains and culture conditions
------------------------------------

All yeast strains used in this study ([Table 1](#T1){ref-type="table"}) are in the W303 background (*ade2-1 can1-100, his3-1,15 leu2-3112 trp1-1 ura3).* Epitope-tagged strains were generated using a published tagging system ([@B36]). For expression of Met4 in the absence of Met30 in studies, *met4::GAL-MET4 met30*Δ, *met4::GAL-MET4 met30Δ met31Δ met32*Δ, *met4::GAL-MET4 met30Δ met31*Δ, and *met4::GAL-MET4 met30Δ met32*Δ were grown in XY media (2% bactopeptone, 1% yeast extract, 0.01% adenine, and 0.02% tryptophan) + 2% raffinose. An aliquot of cells was harvested for a t = 0 time point, and galactose was added to the remaining culture to a final concentration of 2--3%. Cells were harvested after 30, 60, and 90 min in galactose. For the yeast spot assays, indicated strains were serially diluted 10-fold onto B-media agarose plates using different sulfur compounds as the sole sulfur source (the protocol for making B-media plates is described by [@B11]). For sulfur limitation Northern and Western studies, *WT*, *met4*Δ, and *met31Δ met32*Δ strains were grown in minimal B-media (see [@B11], for B-media composition) supplemented with 0.5 mM methionine as the sole sulfur source. An aliquot of cells was harvested for a t = 0 time point, and the remainder was filtered through a 0.22-μm Stericup filter (Millipore, Billerica, MA), then washed and resuspended in prewarmed (30°C) B-media lacking any source of sulfur. Cells were harvested after 20, 40, and 80 min.

###### 

Yeast strains use in this study.

  Strain     Relevant genotype                                                          Source
  ---------- -------------------------------------------------------------------------- ----------------------------------
  yMT-235    *MATa, ade2-1 can1-100, his3-1, 15 leu2-3, 112 trp1-1 ura3*                K. Nasmyth, University of Oxford
  yMT-1465   *MATa, met31:TRP1, met32::HIS3*                                            [@B7]
  yMT-1782   *MATa, met28::LEU2*                                                        [@B32]
  yMT-1813   *MATa, met4::TRP1*                                                         [@B48]
  yMT-1947   *MATa, cbf1::TRP1*                                                         [@B48]
  yMT-2567   *MATa RPB3::3HA-TRP1, MET31::11MYC-his5+*                                  [@B32]
  yTAL-270   *MATα, met32::URA3*                                                        This study
  yTAL-276   *MATa, met31::leu2::URA3*                                                  This study
  yTAL-307   *MATa, met4::GAL1MET4, met30::LEU2*                                        This study
  yTAL-308   *MATa, met4::GAL1MET4, met30::LEU2, met31::leu2::URA3*                     This study
  yTAL-316   *MATa, met4::GAL1MET4, met30::LEU2, met32::URA3*                           This study
  yTAL-319   *MATa, met4::GAL1MET4, met30::LEU2, met31::TRP1, met32::HIS3*              This study
  yTAL-330   *MATα met4::GAL1MET4, met30::LEU2, RPB3::3HA-TRP1, MET31::11MYC- his5+*    This study
  yTAL-361   *MATa, met4::GAL1MET4, met30::LEU2, RPB3::3HA-TRP1, MET32::11MYC- his5+*   This study

Microarray analysis
-------------------

The transcriptional microarrays were produced at the Samuel Lunenfeld Research Institute, Mount Sinai Hospital (Toronto, Canada; [www.mshri.on.ca/microarray](http://www.mshri.on.ca/microarray)), and consist of long oligo (70-mer) gene sets from Qiagen Operon (Alameda, CA). Data were loaded into R and the linear model for microarray analysis (limma) using either the yeast 6.4k version 2 or the version 3 GenePix definition files. Median values were selected for signal and background in F635 and F532. Data representing buffer and oligo mixtures were removed, and Q-site values were reduced to 50% of their weight to perform print-tip loess normalization. Because arrays showed low background, we did not apply background correction. To further normalize between arrays, we used the standard quantile method. To keep consistent replicates for further analysis, we calculated a linear fit between and within array duplicates for each gene to assess the significance of differential expression between different experimental conditions. Limma uses an empirical Bayes method to construct an LOD score to adjust for the statistical significance. To display the data as a heat map across all arrays, we used the robust Z-score : x -- median(sample)/median absolute deviation(sample) × 1.4826 either on top of the Bayesian LOD scores or log fold change between the two channels. The reported p-value was adjusted based on the false-discovery rate function in limma. The raw and normalized data are available at [www.ebi.ac.uk/microarray-as/ae](http://www.ebi.ac.uk/microarray-as/ae) under accession number E-MEXP-3301.

Average hierarchical clustering was performed using the Cluster 3 program ([@B14]), and heat maps were produced using the Java Treeview program ([@B50]). Venn diagrams were produced using online VENNY software ([@B40]) and the Venn Diagram Plotter program from the Pacific Northwest National Laboratory (Richland, WA) at <http://omics.pnl.gov>. Functional specification analysis of transcripts was performed using the Funspec Web portal at <http://funspec.ccbr.utoronto.ca> ([@B47]). As stated in [@B47]), the p value for each enrichment was calculated using hypergeometric distribution and subsequent Bonferroni correction and represents the probability of finding such an enrichment by chance. Target sequences were retrieved using the online Regulatory Sequence Analysis Tools program at <http://rsat.ulb.ac.be/rsat/>. MEME analysis was performed using the online program at <http://meme.sdsc.edu/meme4_6_1/intro.html> ([@B3]).

Northern analysis
-----------------

Northern analysis was conducted as previously described ([@B60]). Northern blots were probed with ORF fragments that were amplified using PCR and random primed with ^32^P-α-dATP using the Klenow fragment of DNA polymerase I (New England BioLabs, Ipswich, MA). Transcript abundance was quantitated by a Cyclone Phosphorimager Detection System (PerkinElmer, Waltham, MA) and normalized to *ACT1* mRNA levels.

Western analysis
----------------

Western analyses were conducted as previously described ([@B5]). Standard procedures were used for PAGE, semidry or wet transfer to polyvinylidene fluoride membranes, and immunoblotting. 12CA5 (Santa Cruz Biotechnology, Santa Cruz, CA), 9E10 (Santa Cruz Biotechnology), anti-Rpb3 (Neoclone, Madison, WI), and anti-Rpb1 (Neoclone) monoclonal antibodies, as well as polyclonal antibodies against Met4, Met32, and Cbf1, were used as previously described ([@B30]; [@B5]; [@B32]).

ChIP-chip analysis
------------------

ChIP-chip was performed in duplicate, as previously described, with some modifications ([@B18]). Briefly, 50-ml cultures were grown in rich media to an O.D.~600~ of 0.6--0.8 and fixed with 1% formaldehyde as described. Sonicated whole-cell extract was incubated with anti-Met4 antibodies, anti-Met32 antibodies, or no antibodies (control) and protein A--Sepharose beads. The immunoprecipitated DNA fragments were blunted with T4 DNA polymerase and ligated to unidirectional linkers. The DNA was then amplified by PCR in the presence of aminoallyl-modified dUTP. The labeling was carried out post PCR using monoreactive Cy-dye NHS esters that react specifically with the aminoallyl-modified dUTP. Control and experimental samples were combined, and the labeled DNA was hybridized to a yeast whole-genome high-density oligonucleotide ChIP-on-chip microarray (4× 44K; Agilent Technologies, Santa Clara, CA) at the University Health Network Microarray Centre (Toronto, Canada; [www.microarrays.ca](http://www.microarrays.ca)). These microarrays contain 60-mer probes covering the entire genome (except for repetitive regions) with an average density of one probe every 290 base pairs within the probed regions. Hybridization and washes were done according to Agilent Yeast ChIP-chip protocol. Detailed ChIP-chip protocol can be found at [www.ircm.qc.ca/LARECHERCHE/axes/Biologie/Chromatine/Pages/default.aspx](http://www.ircm.qc.ca/LARECHERCHE/axes/Biologie/Chromatine/Pages/default.aspx). Microarray were scanned with a GenePix 4000B (Molecular Devices, Sunnyvale, CA). Spots were found and quantitated with GenePix Pro (Molecular Devices). Data were analyzed as previously described ([@B46]). Hybridization data were preprocessed using ArrayPipe 1.7 ([@B23]). Background was subtracted using the "foreground--background" correction method, and the data were normalized using the limma loess (subgrid) method. Genome-wide location data were analyzed as described previously ([@B9]; [@B45]). Briefly, ChIP enrichment was determined for each probe after normalization. For each array, the p value was calculated for each probe using an error model. Probes that scored significantly above background were then combined into probe sets of three probes if they passed the following filter: the center probe has p \< 0.001, one of the flanking probes has p \< 0.01, and two of the three probes in the probe set each has single probe p \< 0.005. The raw and normalized data are available at [www.ebi.ac.uk/microarray-as/ae](http://www.ebi.ac.uk/microarray-as/ae) under accession number E-MEXP-3302. Target sequences were retrieved using the online Regulatory Sequence Analysis Tools program at <http://rsat.ulb.ac.be/rsat>. MEME analysis was performed using the online program at <http://meme.sdsc.edu/meme4_6_1/intro.html> ([@B3]). MEME CHIP analysis was performed using the online program at <http://meme.sdsc.edu/meme/cgi-bin/meme-chip.cgi> ([@B37]).

Single-promoter ChIP analysis
-----------------------------

ChIP analyses were conducted as previously described ([@B30]). Anti-hemagglutinin (F-7) and anti--c-Myc (9E10) antibodies were purchased from Santa Cruz Biotechnology. Multiplex real-time quantitative PCR on ChIP samples was conducted as previously described ([@B26]), except that the IQ5 real-time PCR detection and analysis system (Bio-Rad, Hercules, CA) was used. See [@B32]) for sequence of real-time primers and probes. Relative promoter binding of each transcription factor was compared as a color scale, with red indicating binding and black indicating no binding. For each tagged or untagged protein on which ChIP was conducted, ChIP efficiency for all promoters was represented relative to the highest captured promoter, which was assigned a value of 100%.
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ChIP

:   chromatin immunoprecipitation

ChIP-chip

:   genome-wide chromatin immunoprecipitation
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:   open reading frame
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:   ribosomal protein
